Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laird

Showing results (291-300 of 304) with videos related to

Pageof 31
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints SeriesOlav Dajani, Iain Philips, Ester Kristine Størkson, et al.
The Journal of Clinical Investigation|February 6, 2018
Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesisBeiyun Zhou, Per Flodby, Jiao Luo, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 12, 2024
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints seriesOla Magne Vagnildhaug, Trude R Balstad, Inger Ottestad, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 13, 2024
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints seriesLeo R Brown, Mariana S Sousa, Michael S Yule, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 29, 2024
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints seriesMarianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2024
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint seriesMichael S Yule, Joshua Thompson, Khachonphat Leesahatsawat, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 6, 2023
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints seriesJames McDonald, Judith Sayers, Stefan D Anker, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications|January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications|February 28, 2014
Characterizing the genetic basis of methylome diversity in histologically normal human lung tissueJianxin Shi, Crystal N Marconett, Jubao Duan, et al.
Pageof 31

Showing results (291-300 of 304) with videos related to

Sort By:
Pageof 31
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints SeriesOlav Dajani, Iain Philips, Ester Kristine Størkson, et al.
The Journal of Clinical Investigation|February 6, 2018
Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesisBeiyun Zhou, Per Flodby, Jiao Luo, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 12, 2024
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints seriesOla Magne Vagnildhaug, Trude R Balstad, Inger Ottestad, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 13, 2024
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints seriesLeo R Brown, Mariana S Sousa, Michael S Yule, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 29, 2024
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints seriesMarianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2024
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint seriesMichael S Yule, Joshua Thompson, Khachonphat Leesahatsawat, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 6, 2023
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints seriesJames McDonald, Judith Sayers, Stefan D Anker, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications|January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications|February 28, 2014
Characterizing the genetic basis of methylome diversity in histologically normal human lung tissueJianxin Shi, Crystal N Marconett, Jubao Duan, et al.
Pageof 31